1-20 of 103
Katie Robinson
Close
Sort by
News

Circulating Tumor DNA Analysis Identifies Classical Hodgkin Lymphoma Genotypes

Free
Katie Robinson
Published: 2025
Abstract
June 2025
View News titled, Circulating Tumor DNA Analysis Identifies Classical Hodgkin Lymphoma Genotypes
News

Daratumumab Shows Clinical Activity, No New Safety Concerns With Extended Use in Intermediate/High-Risk Smoldering MM

Free
Katie Robinson
Published: 2025
Abstract
June 2025
View News titled, Daratumumab Shows Clinical Activity, No New Safety Concerns With Extended Use in Intermediate/High-Risk Smoldering MM
News

Cilta-Cel Shows Superior Efficacy, Survival Over Ide-Cel, but Higher Toxicity in R/R MM

Free
Katie Robinson
Published: 2025
Abstract
June 2025
View News titled, Cilta-Cel Shows Superior Efficacy, Survival Over Ide-Cel, but Higher Toxicity in R/R MM
News

Cyclophosphamide May Mitigate Movement, Neurocognitive Treatment-Emergent Adverse Events Following Cilta-Cel for R/R MM

Free
Katie Robinson
Published: 2025
Abstract
June 2025
View News titled, Cyclophosphamide May Mitigate Movement, Neurocognitive Treatment-Emergent Adverse Events Following Cilta-Cel for R/R MM
News

Clonal Hematopoiesis Linked to Increased Risk for Heart Failure, Non-Relapse Mortality After AHCT for Lymphoma

Free
Katie Robinson
Published: 2025
Abstract
April 2025
View News titled, Clonal Hematopoiesis Linked to Increased Risk for Heart Failure, Non-Relapse Mortality After AHCT for Lymphoma
News

DNMT3A Mutations Found in Frequent Blood Donors, But No Clonal Hematopoiesis Increase

Free
Katie Robinson
Published: 2025
Abstract
April 2025
View News titled, DNMT3A Mutations Found in Frequent Blood Donors, But No Clonal Hematopoiesis Increase
News

Front-Line Brentuximab Vedotin, Nivolumab Plus Chemotherapy Shows Durable Response, Acceptable Safety in Advanced cHL

Free
Katie Robinson
Published: 2025
Abstract
April 2025
View News titled, Front-Line Brentuximab Vedotin, Nivolumab Plus Chemotherapy Shows Durable Response, Acceptable Safety in Advanced cHL
News

Clonal Hematopoiesis Associated With Cytopenias After CAR-T Therapy for MM

Free
Katie Robinson
Published: 2025
Abstract
April 2025
View News titled, Clonal Hematopoiesis Associated With Cytopenias After CAR-T Therapy for MM
News

Pacritinib Response Linked to Survival in Myelofibrosis With Thrombocytopenia

Free
Katie Robinson
Published: 2025
Abstract
March 2025
View News titled, Pacritinib Response Linked to Survival in Myelofibrosis With Thrombocytopenia
News

Odronextamab Monotherapy Appears Safe, Effective in R/R DLBCL With Progression After CAR-T

Free
Katie Robinson
Published: 2025
Abstract
March 2025
View News titled, Odronextamab Monotherapy Appears Safe, Effective in R/R DLBCL With Progression After CAR-T
News

Study of LBCL Confirms Prognostic Value of ctDNA in Second-Line Liso-Cel Versus Standard of Care

Free
Katie Robinson
Published: 2025
Abstract
April 2025
View News titled, Study of LBCL Confirms Prognostic Value of ctDNA in Second-Line Liso-Cel Versus Standard of Care
News

Clonal Hematopoiesis May Prolong Cytopenias After CAR-T Therapy for MM

Free
Katie Robinson
Published: 2025
Abstract
February 2025
View News titled, Clonal Hematopoiesis May Prolong Cytopenias After CAR-T Therapy for MM
News

CAR-T Shows Acceptable Efficacy, Safety in Phase II R/R T-ALL/LBL Study

Free
Katie Robinson
Published: 2025
Abstract
April 2025
View News titled, CAR-T Shows Acceptable Efficacy, Safety in Phase II R/R T-ALL/LBL Study
News

Cilta-Cel Treatment in Lenalidomide-Refractory MM Results in High Rates of MRD Negativity

Free
Katie Robinson
Published: 2025
Abstract
April 2025
View News titled, Cilta-Cel Treatment in Lenalidomide-Refractory MM Results in High Rates of MRD Negativity
News

Study Highlights Characteristics of Post-CAR-T Treatment–Related Myeloid Neoplasms

Free
Katie Robinson
Published: 2025
Abstract
April 2025
View News titled, Study Highlights Characteristics of Post-CAR-T Treatment–Related Myeloid Neoplasms
News

Relapse-Free Survival Progressively Shortens in Black Patients With Rituximab-Treated iTTP

Free
Katie Robinson
Published: 2025
Abstract
February 2025
View News titled, Relapse-Free Survival Progressively Shortens in Black Patients With Rituximab-Treated iTTP
News

Danicopan Plus Ravulizumab, Eculizumab Shows Long-Term Efficacy in PNH With Clinically Significant EVH

Free
Katie Robinson
Published: 2025
Abstract
February 2025
View News titled, Danicopan Plus Ravulizumab, Eculizumab Shows Long-Term Efficacy in PNH With Clinically Significant EVH
News

Therapy-Related Acute Leukemia Following AHCT for MM Remains Uncommon, Outcomes Remain Poor in Retrospective Analysis

Free
Katie Robinson
Published: 2025
Abstract
February 2025
View News titled, Therapy-Related Acute Leukemia Following AHCT for MM Remains Uncommon, Outcomes Remain Poor in Retrospective Analysis
News

EMD Lesions Comprise Multicellular Ecosystems With New Therapeutic Avenues

Free
Katie Robinson
Published: 2025
Abstract
February 2025
View News titled, EMD Lesions Comprise Multicellular Ecosystems With New Therapeutic Avenues
News

Daratumumab Plus Lenalidomide Shows MRD, PFS Benefit in Newly Diagnosed MM After AHCT in Clinically Relevant Subgroups

Free
Katie Robinson
Published: 2024
Abstract
January 2025
View News titled, Daratumumab Plus Lenalidomide Shows MRD, PFS Benefit in Newly Diagnosed MM After AHCT in Clinically Relevant Subgroups